SCHEMBL7913752

SCHEMBL7913752

C=S(C)(=O)N(C)c1nc(-c2ccc(F)cc2)c(C)c(C(C)C)n1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 6/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP3A4 P08684 1/20 0.46
PDE6D O43924 1/20 0.46
NR1I2 O75469 1/20 0.46
PDE4D Q08499 1/20 0.46
ABCC3 O15438 1/20 0.45
ABCC4 O15439 1/20 0.45
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
AKT1 P31749 2/20 0.42
PTGS2 P35354 3/20 0.40
PTGS1 P23219 2/20 0.40
GCGR P47871 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL431291 0.90 HMGCR (0.55) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL10129494 0.82 GCGR (0.46) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL6869840 0.79 GCGR (0.44) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL4620964 0.79 HMGCR (0.54) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL28860507 0.78 HMGCR (0.56) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL13010709 0.78 GCGR (0.43) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL6804623 0.78 HMGCR (0.55) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL16429688 0.78 HMGCR (0.43) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL2219461 0.77 HMGCR (0.62) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL14403869 0.77 HMGCR (0.56) HMGCRALDH1A1CYP3A4PDE6DNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2391609-B1 KEY INTERMEDIATES FOR THE SYNTHESIS OF ROSUVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF LEK PHARMACEUTICALS (SI) 2015-01-28 EP disclosed
WO-2010086438-A1 KEY INTERMEDIATES FOR THE SYNTHESIS OF ROSUVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF LEK PHARMACEUTICALS D.D. (SI) 2010-08-05 WO disclosed